[Inhibition of thrombocyte aggregation as a therapeutic principle. Review of the literature and currently approved thrombocyte aggregation inhibitors].
Huber
K
K
Abteilung für Hämatologie und Internistische Onkologie am Klinikum der Universität Regensburg. karl.huber@klinik.uni-regensburg.de
Andreesen
R
R
D002986:Clinical Trials as Topic; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology
D010975:Platelet Aggregation Inhibitors